Medlab Clinical (AU:MDC) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Medlab Clinical Limited reported a significant 98.7% drop in revenue, amounting to just $11,894, and a reduced net loss of $2.13 million for the year ended June 2024. The company did not declare any dividends during this period, reflecting ongoing financial challenges. Despite these setbacks, Medlab remains committed to navigating its financial hurdles.
For further insights into AU:MDC stock, check out TipRanks’ Stock Analysis page.